F

FIMECS, Inc.

13 employees

FIMECS is a focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Immuno-oncology
Protein Degrader
Undruggable
Targeted Protein Degradation
Drug Discovery
Bi-functional Compound
Oncology
Mid-size Molecule
Medical
Pseudokinase

Date founded

2018

Funding rounds raised

Total raised

$5.1M

from 3 investors over 3 rounds

F

FIMECS, Inc. raised $5.1M on May 28, 2020

Investors: Kyoto University Innovation Capital Co., Ltd, ANRI and UTokyo Innovation Platform Co., Ltd.

FAQ